-
Navigating HTA Requirements: The Current Landscape of Alzheimer's Disease-Modifying Treatments
Sep 9, 2025, 16:22 PM -
Differential Responsiveness and Minimally Important Difference of EQ-5D: Truth or Artifact?
Sep 9, 2025, 16:22 PM -
Environmental Impact of Psychiatric Outpatient Visit: Emissions Analysis of Travel and the Sustainability Potential of Remote Consultations
Sep 9, 2025, 16:22 PM -
Why TSD26 Matters: How Accurate Was Clinical Expert Opinion in Estimating Long-Term Outcomes?
Sep 9, 2025, 16:22 PM -
EQ-5D Utility Impact of Worsening NYHA Class and CV Hospitalization (CVH) on Health-Related Quality of Life (HRQoL) of Patients With ATTR-CM Based on the ATTRibute-CM Trial
Sep 9, 2025, 16:22 PM -
First-Line Immunotherapies for Advanced Biliary Tract Cancer: A Systematic Review of Economic Studies
Sep 9, 2025, 16:22 PM -
Role of Real-World Evidence (RWE) in Pricing and Reimbursement Decisions for Rare Disease in Health Technology Assessment (HTA) Submissions Across EU4 + UK
Sep 9, 2025, 16:22 PM -
The Relevance of the Use of TENS Devices in the Therapy of Poststroke Dysphagia
Sep 9, 2025, 16:22 PM -
EU HTA JCA PICO Consolidation Process Examples: Key Trends and Remaining Uncertainties
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Delgocitinib vs. PUVA in Patients With Moderate-to-Severe Chronic Hand Eczema
Sep 9, 2025, 16:22 PM -
Systematic Literature Review and Bayesian Network Meta-Analysis of Sugemalimab Plus Chemotherapy vs. Other First-Line Treatments for Metastatic Non-Small Cell Lung Cancer Without Sensitizing eGFR, ALK, ROS1, or RET Alterations
Sep 9, 2025, 16:22 PM -
Impact of Delayed or Missing Diagnosis of Chronic Kidney Disease
Sep 9, 2025, 16:22 PM -
Literature Review on the Economic Impact of Maternal Fetal Infections
Sep 9, 2025, 16:22 PM -
Integrating Patient Perspectives in HTA: What Can We Learn to Inform HTA-Focused Value Communications?
Sep 9, 2025, 16:22 PM -
Identification of Real-World Data to Study HAE Unmet Need: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Systemic Therapies in Adults with KRAS(G12C) Metastatic Colorectal Cancer in Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Real-World Evidence on Treatment Patterns and Guidelines in Patients With Advanced Merkel Cell Carcinoma Across the US and Europe
Sep 9, 2025, 16:22 PM -
Trends and Scope of Japan’s Across-the-Board Pharmaceutical Price Revisions in FY2021-25
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of Targeted-Release Form (TRF)-Budesonide for the Treatment of Adult Population With Immunoglobulin A Nephropathy (IgAN) in Greece
Sep 9, 2025, 16:22 PM -
Estimating Lost Life-Years and Quality-Adjusted Life-Years of Undertreatment of Patients With Renal Cell Carcinoma and Metastatic Pancreatic Cancer in England
Sep 9, 2025, 16:22 PM
